方法假设和共变量对ROC分析中截止值估计的影响
1Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Biometrical journal. Biometrische Zeitschrift
|April 28, 2025
概括
这项研究引入了一个基于共变量的框架,用于疾病诊断中最佳的生物标志物切断,这对于准确的患者分类至关重要. 它评估了接收器操作特征 (ROC) 曲线估计方法,以提高诊断准确性,特别是在阿尔茨海默氏症中.
科学领域:
- 生物统计学 生物统计学
- 医学诊断 医学诊断 医学诊断
- 生物标志物研究 生物标志物研究
背景情况:
- 接收器操作特征 (ROC) 曲线对于评估诊断生物标志物的有效性和确定最佳切断值至关重要.
- 现有的切断值估计方法往往忽视了共变量对诊断绩效的重大影响.
- 跨共变量水平的诊断总结的变化需要对共变量特定的最佳切线确定.
研究的目的:
- 开发和评估一个基于共变量的框架,用于估计最佳生物标志物切断值.
- 调查不同ROC曲线估计方法对切线估计的影响.
- 通过使用ADNI数据评估生物标志物性能并确定阿尔茨海默病诊断的最佳切断值.
主要方法:
- 在各种场景下进行了广泛的模拟研究,以仔细检查ROC曲线估计模型.
- 结合了各种数据生成机制和模拟中的共同变量效应.
- 利用阿尔茨海默病神经成像计划 (ADNI) 数据集进行现实世界生物标志物评估.
主要成果:
- 证明了不同的ROC曲线估计模型在估计最佳切断时的性能.
- 确定了具有阿尔茨海默病诊断潜力的特定生物标志物.
- 在ADNI队列中确定了这些生物标志物的合适最佳切断值.
结论:
- 基于共变量的框架对于基于生物标志物的疾病诊断中准确,量身定制的最佳切线是必不可少的.
- 选择ROC曲线估计方法会显著影响截止值估计的准确性.
- 这项研究为优化诊断策略提供了强有力的方法,特别是对于阿尔茨海默病.
相关概念视频
01:15Receiver Operating Characteristic Plot
62
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
62
01:15Assumptions of Survival Analysis
56
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
56
01:20Comparing the Survival Analysis of Two or More Groups
84
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
84
01:24Kaplan-Meier Approach
52
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
52
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
01:09Censoring Survival Data
40
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
40